Hematology Analyzers and Reagents Market Size, Share & Trends by Product (Instrument (PoC, Semi-automated), Reagent, Consumable, Service), Price (High, Mid, Low), Application (Anemia, Blood Cancer), End User (Hospital, CTL, Govt Lab, Blood Bank) - Global Forecast to 2029
The global hematology analyzers and reagents market is projected to reach USD 8.8 billion by 2029 from USD 6.6 billion in 2024, growing at a CAGR of 6.1% during the forecast period. The technological advancements of hematology analyzers and reagents methods are one of the major factors anticipated to boost market growth in the forecasting years. Additionally, the high cost of hematology analyzers and reagents, the lack of skilled professionals in emerging countries, along the slow adoption of advanced hematology instruments in emerging economies affect the growth of the hematology analyzers and reagents market.
“The hematology products and services segment to hold the largest share of the market in 2024.”
Based on product and services, hematology analyzers and reagents are segmented into hematology products and services, hemostasis products and services and immunohematology products and services. The hematology products & services segment is expected to dominate the hematology analyzers and reagents market during the forecast period. Further the hematology products & services segment is divided into three sub-segments: instruments, reagents and consumables and services. With the increasing adoption of POC testing hematology analyzers in emerging economies and the launch of technologically advanced hematology products worldwide leads to the growth of this market segment.
“The low-range hematology analyzers segment to hold the largest share of the market in 2024.”
Based on price range, the hematology analyzers and reagents market is segmented into high-range hematology analyzers, mid-range hematology analyzers and low-range hematology analyzers. The hematology analyzers and reagents market is expected to be dominated by the low-range hematology analyzers segment during the forecast period. The low-range hematology analyzers are expected to grow due to their affordable costing compared to high-range hematology analyzers and mid-range hematology analyzers
“The standalone analyzers segment to hold the largest share of the market in 2024.”
Based on the usage type, the hematology analyzers and reagents market is segmented into standalone analyzers and point-of-care analyzers segments. The standalone analyzers segment is projected to dominate the hematology analyzers and reagents market throughout the forecast period. Growing adoption of these systems in acute care settings for hospitals and reference laboratories. leads to the increasing growth of the segment in the market.
“The commercial service providers segment to hold the largest share of the market in 2024.”
The end user market is segmented into commercial service providers, hospital laboratories, government reference laboratories, and research & academic institutes. Commercial service providers accounted for the largest share of the global hematology analyzers and reagents market in 2023 during the forecasted years. This can be attributed to the attributed to the growing outsourcing of R&D activities to commercial service providers especially in emerging economies.
“The market in the APAC region is expected to register highest growth rate for hematology analyzers and reagents in 2024.”
The hematology analyzers and reagents market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2023, a significant market share for hematology analyzers and reagents was held by the market in the North American region, comprising the US and Canada. On the other hand, the Asia Pacific market is estimated to register the highest growth rate during the forecast period. The increasing market penetration opportunities in emerging APAC countries led to the growth of the hematology analyzers and reagents market in this region.
A breakdown of the primary participants referred to for this report is provided below:
Research Coverage
This report studies the hematology analyzers and reagents market based on product and services, price range, application, modality, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.
This report provides insights on the following pointers:
“The hematology products and services segment to hold the largest share of the market in 2024.”
Based on product and services, hematology analyzers and reagents are segmented into hematology products and services, hemostasis products and services and immunohematology products and services. The hematology products & services segment is expected to dominate the hematology analyzers and reagents market during the forecast period. Further the hematology products & services segment is divided into three sub-segments: instruments, reagents and consumables and services. With the increasing adoption of POC testing hematology analyzers in emerging economies and the launch of technologically advanced hematology products worldwide leads to the growth of this market segment.
“The low-range hematology analyzers segment to hold the largest share of the market in 2024.”
Based on price range, the hematology analyzers and reagents market is segmented into high-range hematology analyzers, mid-range hematology analyzers and low-range hematology analyzers. The hematology analyzers and reagents market is expected to be dominated by the low-range hematology analyzers segment during the forecast period. The low-range hematology analyzers are expected to grow due to their affordable costing compared to high-range hematology analyzers and mid-range hematology analyzers
“The standalone analyzers segment to hold the largest share of the market in 2024.”
Based on the usage type, the hematology analyzers and reagents market is segmented into standalone analyzers and point-of-care analyzers segments. The standalone analyzers segment is projected to dominate the hematology analyzers and reagents market throughout the forecast period. Growing adoption of these systems in acute care settings for hospitals and reference laboratories. leads to the increasing growth of the segment in the market.
“The commercial service providers segment to hold the largest share of the market in 2024.”
The end user market is segmented into commercial service providers, hospital laboratories, government reference laboratories, and research & academic institutes. Commercial service providers accounted for the largest share of the global hematology analyzers and reagents market in 2023 during the forecasted years. This can be attributed to the attributed to the growing outsourcing of R&D activities to commercial service providers especially in emerging economies.
“The market in the APAC region is expected to register highest growth rate for hematology analyzers and reagents in 2024.”
The hematology analyzers and reagents market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2023, a significant market share for hematology analyzers and reagents was held by the market in the North American region, comprising the US and Canada. On the other hand, the Asia Pacific market is estimated to register the highest growth rate during the forecast period. The increasing market penetration opportunities in emerging APAC countries led to the growth of the hematology analyzers and reagents market in this region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1– 25%, Tier 2– 30%, and Tier 3– 45%
- By Designation: D-level– 30%, C- Level– 23%, and Others– 47%
- By Region: North America– 40%, Europe– 30%, Asia Pacific– 22%, Latin America- 6%, MEA- 2%
Research Coverage
This report studies the hematology analyzers and reagents market based on product and services, price range, application, modality, end user, and region. It also covers the factors affecting market growth, analyzes the various opportunities and challenges in the market, and provides details of the competitive landscape for market leaders. Furthermore, the report analyzes micro markets with respect to their individual growth trends and forecasts the revenue of the market segments with respect to five main regions (and the respective countries in these regions).
Reasons to Buy the Report
The report will enable established firms as well as entrants/smaller firms to gauge the pulse of the market, which, in turn, would help them to garner a larger market share. Firms purchasing the report could use one or a combination of the below-mentioned strategies to strengthen their market presence.
This report provides insights on the following pointers:
- Analysis of key drivers (Increasing need for technological advancements, Integration of hematology analyzers with flow cytometry, Increasing number of blood donations), restraints (High costs associated with advanced hematology analyzers), opportunities (Increased awareness among end users about advanced hematology analyzers, Increasing market penetration opportunities in emerging countries, Emergence of microfluidics), and challenges (Stringent and time-consuming regulatory process) influencing the growth of the hematology analyzers and reagents market
- Market Penetration: Comprehensive information on the product portfolios offered by the top players in the hematology analyzers and reagents market
- Service Development/Innovation: Detailed insights on the upcoming trends, R&D activities, and service developments in the hematology analyzers and reagents market
- Market Development: Comprehensive information on lucrative emerging regions
- Market Diversification: Exhaustive information about new services, growing geographies, and recent developments in the hematology analyzers and reagents market
- Competitive Assessment: In-depth assessment of market segments, growth strategies, revenue analysis, and services of the leading market players.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 MARKET STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 List of secondary sources
2.1.2 PRIMARY DATA
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 PRODUCT-BASED MARKET ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION AND MARKET BREAKDOWN
2.4 RESEARCH ASSUMPTIONS
2.4.1 STUDY ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
2.6 RISK ASSESSMENT
2.6.1 RISK ASSESSMENT ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 HEMATOLOGY ANALYZERS AND REAGENTS MARKET OVERVIEW
4.2 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT AND COUNTRY (2023)
4.3 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: REGIONAL MIX,
2022–2029 (USD MILLION)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing incidence of blood disorders
5.2.1.2 Growing number of blood donations
5.2.1.3 Rising technological advancements
5.2.1.4 Integration of hematology analyzers with flow cytometry
5.2.2 RESTRAINTS
5.2.2.1 High cost of advanced hematology analyzers
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing uptake of automated hematology analyzers
5.2.3.2 Growth potential of emerging economies
5.2.3.3 Emergence of microfluidics
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory guidelines
5.2.4.2 Shortage of skilled professionals in emerging markets
5.3 REGULATORY SCENARIO
5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.3.2 REGULATORY TRENDS
5.3.2.1 North America
5.3.2.1.1 US
5.3.2.2 Europe
5.3.2.3 Asia Pacific
5.3.2.3.1 India
5.3.2.3.2 China
5.4 REIMBURSEMENT SCENARIO
5.5 VALUE CHAIN ANALYSIS
5.5.1 RESEARCH & DEVELOPMENT
5.5.2 PROCUREMENT & PRODUCT DEVELOPMENT
5.5.3 MARKETING, SALES, AND DISTRIBUTION
5.6 SUPPLY CHAIN ANALYSIS
5.6.1 PROMINENT COMPANIES
5.6.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.6.3 END USERS
5.7 ECOSYSTEM ANALYSIS
5.8 PORTER’S FIVE FORCES ANALYSIS
5.8.1 DEGREE OF COMPETITION
5.8.2 BARGAINING POWER OF BUYERS
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 THREAT OF NEW ENTRANTS
5.8.5 THREAT OF SUBSTITUTES
5.9 TRADE DATA ANALYSIS
5.10 PATENT ANALYSIS
5.11 PRICING ANALYSIS
5.12 TECHNOLOGY ANALYSIS
5.12.1 KEY TECHNOLOGIES
5.12.1.1 Flow cytometry
5.12.1.2 Digital microscopy and image analysis
5.12.1.3 Polymerase chain reaction (PCR) and next-generation sequencing (NGS)
5.12.1.4 Microfluidics
5.12.2 ADJACENT TECHNOLOGIES
5.12.2.1 Bioinformatics
5.12.2.2 Wearable health technology
5.12.2.3 Point-of-care testing (POCT) devices
5.12.3 COMPLEMENTARY TECHNOLOGIES
5.12.3.1 Immunohistochemistry (IHC)
5.12.3.2 Spectrophotometry
5.12.3.3 Serological testing
5.13 KEY CONFERENCES AND EVENTS, 2024
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.14.2 KEY BUYING CRITERIA
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.16 INVESTMENT & FUNDING SCENARIO
5.17 UNMET NEEDS
5.18 USE OF GENERATIVE AI IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE
6.1 INTRODUCTION
6.2 HEMATOLOGY PRODUCTS & SERVICES
6.2.1 REAGENTS & CONSUMABLES
6.2.1.1 Hematology reagents
6.2.1.1.1 Growing preference for reagent rental business models to drive market
6.2.1.2 Hematology consumables
6.2.1.2.1 Recurring requirement to boost demand
6.2.1.3 Controls & calibrators
6.2.1.3.1 Ability to monitor multiple parameters to fuel uptake
6.2.1.4 Slide stainers & makers
6.2.1.4.1 Ability to provide reliable & uniform staining results to fuel uptake
6.2.2 INSTRUMENTS
6.2.2.1 5-part and 6-part fully automated hematology analyzers
6.2.2.1.1 Identification and classification of WBCs to drive market
6.2.2.2 3-part fully automated hematology analyzers
6.2.2.2.1 Low maintenance costs to fuel uptake
6.2.2.3 Point-of-care testing hematology analyzers
6.2.2.3.1 Increasing preference towards home testing of blood levels to support market growth
6.2.2.4 Semi-automated hematology analyzers
6.2.2.4.1 Need for manual interruption to restrain market adoption
6.2.3 SERVICES
6.2.3.1 High adoption of diagnostic techniques to boost demand
6.3 HEMOSTASIS PRODUCTS & SERVICES
6.3.1 HEMOSTASIS REAGENTS & CONSUMABLES
6.3.1.1 Rising prevalence of coagulation disorders to support growth
6.3.2 HEMOSTASIS INSTRUMENTS
6.3.2.1 High productivity with low complexities to drive market
6.3.3 HEMOSTASIS SERVICES
6.3.3.1 Advancements in hemostasis diagnostic techniques to support market growth
6.4 IMMUNOHEMATOLOGY PRODUCTS & SERVICES
6.4.1 IMMUNOHEMATOLOGY REAGENTS & CONSUMABLES
6.4.1.1 Development of novel immunohematology reagents to drive market
6.4.2 IMMUNOHEMATOLOGY INSTRUMENTS
6.4.2.1 Growing automation in immunohematology labs to boost demand
6.4.3 SERVICES
6.4.3.1 Provision of customer-focused care to support market growth
7 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE
7.1 INTRODUCTION
7.2 LOW-RANGE HEMATOLOGY ANALYZERS
7.2.1 LOW OPERATING EXPENSES TO BOOST DEMAND
7.3 HIGH-RANGE HEMATOLOGY ANALYZERS
7.3.1 HIGH ACCURACY AND MULTI-PARAMETER APPROACH TO DRIVE MARKET
7.4 MID-RANGE HEMATOLOGY ANALYZERS
7.4.1 INTEGRATION WITH QUALITY CONTROL SOFTWARE TO SUPPORT MARKET GROWTH
8 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 HEMORRHAGIC CONDITIONS
8.2.1 ABILITY TO TRACK HEMOGLOBIN AND HEMATOCRIT VALUES TO DRIVE MARKET
8.3 INFECTIOUS DISEASES
8.3.1 AVAILABILITY OF HIGH-RESOLUTION HEMATOLOGY SCREENING TO PROPEL MARKET
8.4 IMMUNE SYSTEM DISORDERS
8.4.1 GROWING USE OF POC DIAGNOSTICS AND IMMUNOASSAYS TO PROPEL MARKET
8.5 BLOOD CANCER
8.5.1 DETERMINATION OF HEMATOLOGICAL MALIGNANCIES TO FUEL UPTAKE
8.6 ANEMIA
8.6.1 ABILITY TO IDENTIFY ISOCHROMATIC AND MICROCYTIC ANEMIA TO SUPPORT MARKET GROWTH
8.7 OTHER APPLICATIONS
9 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE
9.1 INTRODUCTION
9.2 STANDALONE ANALYZERS
9.2.1 HIGH UPTAKE IN HOSPITALS AND REFERENCE LABORATORIES FOR CRITICAL CARE SETTINGS TO PROPEL MARKET
9.3 POINT-OF-CARE ANALYZERS
9.3.1 LOW SAMPLE REQUIREMENTS AND REMOTE CARE AVAILABILITY TO BOOST DEMAND
10 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER
10.1 INTRODUCTION
10.2 COMMERCIAL SERVICE PROVIDERS
10.2.1 GROWING OUTSOURCING OF R&D ACTIVITIES AND ABILITY TO PERFORM HIGH VOLUME OF TESTS TO PROPEL MARKET
10.3 HOSPITAL LABORATORIES
10.3.1 PROVISION OF POC & FULLY AUTOMATED ANALYZERS TO DRIVE MARKET
10.4 GOVERNMENT REFERENCE LABORATORIES
10.4.1 FREE SERVICES AND RAPID TURNAROUND TIME TO FUEL UPTAKE
10.5 RESEARCH & ACADEMIC INSTITUTES
10.5.1 INCREASING NUMBER OF DRUG DISCOVERY & RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH
11 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 Rising incidence of anemia and hemophilia to drive market
11.2.2 CANADA
11.2.2.1 Growth in organ transplantation procedures to boost demand
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 Rising prevalence of HIV to drive market
11.3.2 FRANCE
11.3.2.1 Stringent regulatory protocols in diagnostics to propel market
11.3.3 UK
11.3.3.1 Rising number of organ transplant procedures to support market growth
11.3.4 ITALY
11.3.4.1 Growing acceptance of hematology-based diagnostics to boost demand
11.3.5 SPAIN
11.3.5.1 Rising establishment of reference laboratories to drive market
11.3.6 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.1.1 Large target patient population to drive market
11.4.2 JAPAN
11.4.2.1 Rising cases of influenza to support market growth
11.4.3 INDIA
11.4.3.1 Rising cases of dengue and malaria to boost demand
11.4.4 AUSTRALIA
11.4.4.1 Rising prevalence of celiac disease to drive market
11.4.5 SOUTH KOREA
11.4.5.1 High healthcare expenditure and introduction of medical coverage for blood transfusion to support market growth
11.4.6 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 BRAZIL
11.5.1.1 Investments by leading hematology analyzers & reagent manufacturers to drive market
11.5.2 MEXICO
11.5.2.1 Growing requirement for glycosylated hemoglobin analysis tests to fuel uptake
11.5.3 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 GCC COUNTRIES
11.6.1.1 Developments in healthcare infrastructure to drive market
11.6.2 REST OF MIDDLE EAST & AFRICA
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
12.3 REVENUE ANALYSIS
12.4 MARKET SHARE ANALYSIS
12.4.1 HEMATOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
12.4.2 HEMOSTASIS PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
12.4.3 IMMUNOHEMATOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
12.4.4 RANKING OF KEY MARKET PLAYERS
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPETITIVE FOOTPRINT: KEY PLAYERS, 2023
12.5.5.1 Company footprint
12.5.5.2 Product & service footprint
12.5.5.3 Application footprint
12.5.5.4 End-user footprint
12.5.5.5 Region footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.7 COMPANY VALUATION & FINANCIAL METRICS
12.7.1 FINANCIAL METRICS
12.7.2 COMPANY VALUATION
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
12.9.2 DEALS
12.9.3 EXPANSIONS
13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 SYSMEX CORPORATION
13.1.1.1 Business overview
13.1.1.2 Products/Services offered
13.1.1.3 Recent developments
13.1.1.3.1 Product/Service launches
13.1.1.3.2 Expansions
13.1.1.4 MnM view
13.1.1.4.1 Key strengths
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses and competitive threats
13.1.2 DANAHER CORPORATION
13.1.2.1 Business overview
13.1.2.2 Products/Services offered
13.1.2.3 MnM view
13.1.2.3.1 Key strengths
13.1.2.3.2 Strategic choices
13.1.2.3.3 Weaknesses and competitive threats
13.1.3 SIEMENS HEALTHINEERS
13.1.3.1 Business overview
13.1.3.2 Products/Services offered
13.1.3.3 Recent developments
13.1.3.3.1 Product/Service launches
13.1.3.3.2 Deals
13.1.3.4 MnM view
13.1.3.4.1 Key strengths
13.1.3.4.2 Strategic choices
13.1.3.4.3 Weaknesses and competitive threats
13.1.4 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
13.1.4.1 Business overview
13.1.4.2 Products/Services offered
13.1.4.3 MnM view
13.1.4.3.1 Key strengths
13.1.4.3.2 Strategic choices
13.1.4.3.3 Weaknesses and competitive threats
13.1.5 ABBOTT LABORATORIES
13.1.5.1 Business overview
13.1.5.2 Products/Services offered
13.1.5.3 Recent developments
13.1.5.3.1 Product approvals
13.1.5.4 MnM view
13.1.5.4.1 Key strengths
13.1.5.4.2 Strategic choices
13.1.5.4.3 Weaknesses and competitive threats
13.1.6 DIATRON
13.1.6.1 Business overview
13.1.6.2 Products/Services offered
13.1.6.3 Recent developments
13.1.6.3.1 Expansions
13.1.7 DREW SCIENTIFIC
13.1.7.1 Business overview
13.1.7.2 Products/Services offered
13.1.8 BIO-RAD LABORATORIES, INC.
13.1.8.1 Business overview
13.1.8.2 Products/Services offered
13.1.8.3 Recent developments
13.1.8.3.1 Product/Service launches & enhancements
13.1.8.3.2 Deals
13.1.9 HORIBA, LTD.
13.1.9.1 Business overview
13.1.9.2 Products/Services offered
13.1.9.3 Recent developments
13.1.9.3.1 Product/Service launches & approvals
13.1.10 NIHON KOHDEN CORPORATION
13.1.10.1 Business overview
13.1.10.2 Products/Services offered
13.1.10.3 Recent developments
13.1.10.3.1 Product/Service launches
13.1.10.3.2 Expansions
13.1.11 EKF DIAGNOSTICS HOLDINGS PLC
13.1.11.1 Business overview
13.1.11.2 Products/Services offered
13.1.11.3 Recent developments
13.1.11.3.1 Product/Service enhancements
13.1.11.3.2 Deals
13.1.12 BOULE DIAGNOSTICS AB
13.1.12.1 Business overview
13.1.12.2 Products/Services offered
13.1.12.3 Recent developments
13.1.12.3.1 PRODUCT/SERVICE LAUNCHES
13.1.12.3.2 Deals
13.1.13 F. HOFFMANN-LA ROCHE LTD.
13.1.13.1 Business overview
13.1.13.2 Products/Services offered
13.1.13.3 Recent developments
13.1.13.3.1 Deals
13.2 OTHER PLAYERS
13.2.1 BIOSYSTEMS: COMPANY OVERVIEW
13.2.2 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
13.2.3 DRUCKER DIAGNOSTICS: COMPANY OVERVIEW
13.2.4 ELITECH GROUP SAS: COMPANY OVERVIEW
13.2.5 ACCUREX: COMPANY OVERVIEW
13.2.6 STRECK: COMPANY OVERVIEW
13.2.7 NEOMEDICA: COMPANY OVERVIEW
13.2.8 CPC DIAGNOSTICS PVT. LTD.: COMPANY OVERVIEW
13.2.9 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
13.2.10 SHENZHEN DYMIND BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
13.2.11 PZ CORMAY S.A.: COMPANY OVERVIEW
13.2.12 PIXCELL MEDICAL: COMPANY OVERVIEW
13.2.13 RAYTO LIFE AND ANALYTICAL SCIENCES CO. LTD.: COMPANY OVERVIEW
13.2.14 ANALYTICON BIOTECHNOLOGIES GMBH: COMPANY OVERVIEW
13.2.15 TULIP DIAGNOSTICS (P) LTD.: COMPANY OVERVIEW
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
TABLE 1 NORTH AMERICA: LIST OF REGULATORY AUTHORITIES IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
TABLE 2 EUROPE: LIST OF REGULATORY AUTHORITIES IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
TABLE 3 ASIA PACIFIC: LIST OF REGULATORY AUTHORITIES IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
TABLE 4 LATIN AMERICA: LIST OF REGULATORY AUTHORITIES IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
TABLE 5 MIDDLE EAST & AFRICA: LIST OF REGULATORY AUTHORITIES IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
TABLE 6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 7 IMPORT DATA FOR HEMATOLOGY ANALYZERS (HS CODE 902780), BY COUNTRY, 2019?2023 (USD)
TABLE 8 EXPORT DATA FOR HEMATOLOGY ANALYZERS (HS CODE 902780), BY COUNTRY, 2019?2023 (USD)
TABLE 9 AVERAGE SELLING PRICE TREND OF HEMATOLOGY PRODUCTS, BY REGION,
2021–2023
TABLE 10 HEMATOLOGY ANALYZERS AND REAGENTS: LIST OF MAJOR CONFERENCES & EVENTS
TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEMATOLOGY PRODUCTS (%)
TABLE 12 KEY BUYING CRITERIA FOR HEMATOLOGY ANALYZERS AND REAGENTS PRODUCTS
TABLE 13 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: CURRENT UNMET NEEDS
TABLE 14 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 15 HEMATOLOGY PRODUCTS & SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 16 HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 17 HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 18 HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 19 HEMATOLOGY REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 20 HEMATOLOGY CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 21 HEMATOLOGY CONTROLS & CALIBRATORS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 22 HEMATOLOGY SLIDE STAINERS & MAKERS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 23 HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 24 HEMATOLOGY INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 25 5-PART AND 6-PART FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET,
BY REGION, 2022–2029 (USD MILLION)
TABLE 26 3-PART FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 27 POINT-OF-CARE TESTING HEMATOLOGY ANALYZERS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 28 SEMI-AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 29 HEMATOLOGY SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 30 HEMOSTASIS PRODUCTS & SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 31 HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 32 HEMOSTASIS REAGENTS & CONSUMABLES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 33 HEMOSTASIS INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 34 HEMOSTASIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 35 IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 36 IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 37 IMMUNOHEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 38 IMMUNOHEMATOLOGY INSTRUMENTS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 39 IMMUNOHEMATOLOGY SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 40 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE,
2022–2029 (USD MILLION)
TABLE 41 LOW-RANGE HEMATOLOGY ANALYZERS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 42 HIGH-RANGE HEMATOLOGY ANALYZERS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 43 MID-RANGE HEMATOLOGY ANALYZERS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 44 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION)
TABLE 45 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR HEMORRHAGIC CONDITIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 46 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2022–2029 (USD MILLION)
TABLE 47 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR IMMUNE SYSTEM DISORDERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 48 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR BLOOD CANCER,
BY REGION, 2022–2029 (USD MILLION)
TABLE 49 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR ANEMIA, BY REGION, 2022–2029 (USD MILLION)
TABLE 50 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 51 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE,
2022–2029 (USD MILLION)
TABLE 52 STANDALONE HEMATOLOGY ANALYZERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 53 POINT-OF-CARE HEMATOLOGY ANALYZERS, BY REGION,
2022–2029 (USD MILLION)
TABLE 54 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 55 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR COMMERCIAL SERVICE PROVIDERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 56 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 57 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR GOVERNMENT REFERENCE LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 58 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 59 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 60 HEMATOLOGY ANALYZERS VOLUME, BY TYPE, 2023 (UNITS)
TABLE 61 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 62 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 63 NORTH AMERICA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 64 NORTH AMERICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 65 NORTH AMERICA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 66 NORTH AMERICA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 67 NORTH AMERICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 68 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRICE RANGE, 2022–2029 (USD MILLION)
TABLE 69 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 70 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY USAGE TYPE, 2022–2029 (USD MILLION)
TABLE 71 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 72 US: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 73 US: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 74 US: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 75 US: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 76 US: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 77 US: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 78 CANADA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 79 CANADA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 80 CANADA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 81 CANADA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 82 CANADA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 83 CANADA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 84 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 86 EUROPE: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 87 EUROPE: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 88 EUROPE: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 89 EUROPE: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 90 EUROPE: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 91 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2022–2029 (USD MILLION)
TABLE 92 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 93 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)
TABLE 94 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 95 GERMANY: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 96 GERMANY: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 97 GERMANY: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 98 GERMANY: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 99 GERMANY: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 100 GERMANY: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 101 FRANCE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 102 FRANCE: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 103 FRANCE: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 104 FRANCE: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 105 FRANCE: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 106 FRANCE: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 107 UK: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 108 UK: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 109 UK: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 110 UK: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 111 UK: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 112 UK: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 113 ITALY: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 114 ITALY: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 115 ITALY: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 116 ITALY: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 117 ITALY: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 118 ITALY: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 119 SPAIN: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 120 SPAIN: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 121 SPAIN: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 122 SPAIN: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 123 SPAIN: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 124 SPAIN: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 125 REST OF EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 126 REST OF EUROPE: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 127 REST OF EUROPE: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 128 REST OF EUROPE: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 129 REST OF EUROPE: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 130 REST OF EUROPE: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 131 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 132 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 133 ASIA PACIFIC: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 134 ASIA PACIFIC: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 135 ASIA PACIFIC: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 136 ASIA PACIFIC: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 137 ASIA PACIFIC: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 138 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2022–2029 (USD MILLION)
TABLE 139 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 140 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY USAGE TYPE, 2022–2029 (USD MILLION)
TABLE 141 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 142 CHINA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 143 CHINA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 144 CHINA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 145 CHINA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 146 CHINA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 147 CHINA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 148 JAPAN: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 149 JAPAN: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 150 JAPAN: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 151 JAPAN: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 152 JAPAN: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 153 JAPAN: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 154 INDIA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 155 INDIA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 156 INDIA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 157 INDIA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 158 INDIA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 159 INDIA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 160 AUSTRALIA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 161 AUSTRALIA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 162 AUSTRALIA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 163 AUSTRALIA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 164 AUSTRALIA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 165 AUSTRALIA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 166 SOUTH KOREA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 167 SOUTH KOREA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 168 SOUTH KOREA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 169 SOUTH KOREA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 170 SOUTH KOREA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 171 SOUTH KOREA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 172 REST OF ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 173 REST OF ASIA PACIFIC: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 174 REST OF ASIA PACIFIC: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 175 REST OF ASIA PACIFIC: HEMATOLOGY REAGENTS & CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 176 REST OF ASIA PACIFIC: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 177 REST OF ASIA PACIFIC: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 178 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 179 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 180 LATIN AMERICA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 181 LATIN AMERICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 182 LATIN AMERICA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 183 LATIN AMERICA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 184 LATIN AMERICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 185 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2022–2029 (USD MILLION)
TABLE 186 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 187 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY USAGE TYPE, 2022–2029 (USD MILLION)
TABLE 188 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 189 BRAZIL: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 190 BRAZIL: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 191 BRAZIL: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 192 BRAZIL: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 193 BRAZIL: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 194 BRAZIL: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 195 MEXICO: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 196 MEXICO: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 197 MEXICO: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 198 MEXICO: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 199 MEXICO: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 200 MEXICO: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 201 REST OF LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 202 REST OF LATIN AMERICA: HEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 203 REST OF LATIN AMERICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 204 REST OF LATIN AMERICA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 205 REST OF LATIN AMERICA: HEMOSTASIS PRODUCTS & SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 206 REST OF LATIN AMERICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 207 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY REGION, 2022–2029 (USD MILLION)
TABLE 208 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 209 MIDDLE EAST & AFRICA: HEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 210 MIDDLE EAST & AFRICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 211 MIDDLE EAST & AFRICA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 212 MIDDLE EAST & AFRICA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 213 MIDDLE EAST & AFRICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 214 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRICE RANGE, 2022–2029 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 216 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY USAGE TYPE, 2022–2029 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 218 GCC COUNTRIES: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 219 GCC COUNTRIES: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 220 GCC COUNTRIES: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 221 GCC COUNTRIES: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 222 GCC COUNTRIES: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 223 GCC COUNTRIES: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 224 REST OF MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 225 REST OF MIDDLE EAST & AFRICA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 226 REST OF MIDDLE EAST & AFRICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 227 REST OF MIDDLE EAST & AFRICA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 228 REST OF MIDDLE EAST & AFRICA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 229 REST OF MIDDLE EAST & AFRICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 230 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
TABLE 231 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DEGREE OF COMPETITION
TABLE 232 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PRODUCT & SERVICE FOOTPRINT
TABLE 233 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: APPLICATION FOOTPRINT
TABLE 234 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: END-USER FOOTPRINT
TABLE 235 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: REGION FOOTPRINT
TABLE 236 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DETAILED LIST OF
KEY STARTUP/SME PLAYERS
TABLE 237 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 238 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020–JUNE 2024
TABLE 239 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DEALS,
JANUARY 2020–JUNE 2024
TABLE 240 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: EXPANSIONS, JANUARY 2020–JUNE 2024
TABLE 241 SYSMEX CORPORATION: COMPANY OVERVIEW
TABLE 242 SYSMEX CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 243 SYSMEX CORPORATION: PRODUCT/SERVICE LAUNCHES,
JANUARY 2020?JUNE 2024
TABLE 244 SYSMEX CORPORATION: EXPANSIONS, JANUARY 2020?JUNE 2024
TABLE 245 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 246 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 247 SIEMENS HEALTHINEERS: COMPANY OVERVIEW
TABLE 248 SIEMENS HEALTHINEERS: PRODUCTS/SERVICES OFFERED
TABLE 249 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2020?JUNE 2024
TABLE 250 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DEALS,
JANUARY 2020?JUNE 2024
TABLE 251 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
TABLE 252 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:
PRODUCTS/SERVICES OFFERED
TABLE 253 ABBOTT LABORATORIES: COMPANY OVERVIEW
TABLE 254 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED
TABLE 255 ABBOTT LABORATORIES: PRODUCT APPROVALS, JANUARY 2020?JUNE 2024
TABLE 256 DIATRON: COMPANY OVERVIEW
TABLE 257 DIATRON: PRODUCTS/SERVICES OFFERED
TABLE 258 DIATRON: EXPANSIONS, JANUARY 2020?JUNE 2024
TABLE 259 DREW SCIENTIFIC: COMPANY OVERVIEW
TABLE 260 DREW SCIENTIFIC: PRODUCTS/SERVICES OFFERED
TABLE 261 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 262 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 263 BIO-RAD LABORATORIES, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2020?JUNE 2024
TABLE 264 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2020?JUNE 2024
TABLE 265 HORIBA, LTD.: COMPANY OVERVIEW
TABLE 266 HORIBA, LTD.: PRODUCTS/SERVICES OFFERED
TABLE 267 HORIBA, LTD.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020?JUNE 2024
TABLE 268 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
TABLE 269 NIHON KOHDEN CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 270 NIHON KOHEN CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2020?JUNE 2024
TABLE 271 NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2020?JUNE 2024
TABLE 272 EKF DIAGNOSTICS HOLDINGS PLC: COMPANY OVERVIEW
TABLE 273 EKF DIAGNOSTICS HOLDINGS PLC: PRODUCTS/SERVICES OFFERED
TABLE 274 EKF DIAGNOSTICS HOLDINGS PLC: PRODUCT/SERVICE ENHANCEMENTS, JANUARY 2020?JUNE 2024
TABLE 275 EKF DIAGNOSTICS HOLDINGS PLC: DEALS, JANUARY 2020?JUNE 2024
TABLE 276 BOULE DIAGNOSTICS AB: COMPANY OVERVIEW
TABLE 277 BOULE DIAGNOSTICS AB: PRODUCTS/SERVICES OFFERED
TABLE 278 BOULE DIAGNOSTICS AB: PRODUCT/SERVICE LAUNCHES,
JANUARY 2020?JUNE 2024
TABLE 279 BOULE DIAGNOSTICS AB: DEALS, JANUARY 2020?JUNE 2024
TABLE 280 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 281 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
TABLE 282 F. HOFFMANN LA-ROCHE LTD.: DEALS, JANUARY 2020?JUNE 2024
FIGURE 1 MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2023)
FIGURE 6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: MARKET SIZE ESTIMATION METHODOLOGY:
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD MILLION)
FIGURE 9 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION,
2024 VS. 2029 (USD MILLION)
FIGURE 10 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE,
2024 VS. 2029 (USD MILLION)
FIGURE 11 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE,
2024 VS. 2029 (USD MILLION)
FIGURE 12 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER,
2024 VS. 2029 (USD MILLION)
FIGURE 13 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: REGIONAL SNAPSHOT
FIGURE 14 INCREASING INCIDENCE OF BLOOD DISORDERS AND RISING NUMBER OF
BLOOD DONATIONS TO DRIVE MARKET
FIGURE 15 HEMATOLOGY PRODUCTS & SERVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
FIGURE 16 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 17 NORTH AMERICA TO DOMINATE HEMATOLOGY ANALYZERS AND REAGENTS MARKET DURING FORECAST PERIOD
FIGURE 18 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 19 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: VALUE CHAIN ANALYSIS
FIGURE 20 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 21 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: ECOSYSTEM ANALYSIS
FIGURE 22 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: ECOSYSTEM MARKET MAP
FIGURE 23 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 24 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PATENT ANALYSIS
FIGURE 25 AVERAGE SELLING PRICE TREND OF HEMATOLOGY ANALYZERS, BY PRODUCT, 2023 (USD)
FIGURE 26 AVERAGE SELLING PRICE TREND OF HEMATOLOGY REAGENTS, BY PRODUCT, 2023 (USD)
FIGURE 27 AVERAGE SELLING PRICE TREND OF HEMATOLOGY ANALYZERS, BY REGION,
2023 (USD)
FIGURE 28 AVERAGE SELLING PRICE TREND OF HEMATOLOGY REAGENTS, BY REGION,
2023 (USD)
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEMATOLOGY PRODUCTS
FIGURE 30 KEY BUYING CRITERIA FOR HEMATOLOGY ANALYZERS AND PRODUCTS
FIGURE 31 TRENDS/DISRUPTIONS IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
FIGURE 32 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: NUMBER OF DEALS & FUNDING ACTIVITIES, BY KEY PLAYER, 2018–2022 (USD MILLION)
FIGURE 33 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022 (USD MILLION)
FIGURE 34 VALUE OF INVESTOR DEALS IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION)
FIGURE 35 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET SNAPSHOT
FIGURE 36 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET SNAPSHOT
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET (2019?2023)
FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET (2023)
FIGURE 39 HEMATOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 40 HEMOSTASIS PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 41 IMMUNOHEMATOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 42 RANKING OF KEY PLAYERS IN HEMATOLOGY ANALYZERS AND
REAGENTS MARKET, 2023
FIGURE 43 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 44 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: COMPANY FOOTPRINT
FIGURE 45 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 46 EV/EBITDA OF KEY VENDORS
FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS
FIGURE 48 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 49 SYSMEX CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 50 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 51 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2023)
FIGURE 52 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:
COMPANY SNAPSHOT (2023)
FIGURE 53 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023)
FIGURE 54 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 55 HORIBA, LTD.: COMPANY SNAPSHOT (2023)
FIGURE 56 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 57 EKF DIAGNOSTICS HOLDINGS PLC: COMPANY SNAPSHOT (2023)
FIGURE 58 BOULE DIAGNOSTICS AB: COMPANY SNAPSHOT (2023)
FIGURE 59 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.3.3 CURRENCY CONSIDERED
1.4 MARKET STAKEHOLDERS
1.5 SUMMARY OF CHANGES
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
2.1.1 SECONDARY DATA
2.1.1.1 List of secondary sources
2.1.2 PRIMARY DATA
2.2 MARKET ESTIMATION METHODOLOGY
2.2.1 REVENUE MAPPING-BASED MARKET ESTIMATION
2.2.2 PRODUCT-BASED MARKET ESTIMATION
2.2.3 PRIMARY RESEARCH VALIDATION
2.3 DATA TRIANGULATION AND MARKET BREAKDOWN
2.4 RESEARCH ASSUMPTIONS
2.4.1 STUDY ASSUMPTIONS
2.5 RESEARCH LIMITATIONS
2.6 RISK ASSESSMENT
2.6.1 RISK ASSESSMENT ANALYSIS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 HEMATOLOGY ANALYZERS AND REAGENTS MARKET OVERVIEW
4.2 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT AND COUNTRY (2023)
4.3 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
4.4 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: REGIONAL MIX,
2022–2029 (USD MILLION)
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Increasing incidence of blood disorders
5.2.1.2 Growing number of blood donations
5.2.1.3 Rising technological advancements
5.2.1.4 Integration of hematology analyzers with flow cytometry
5.2.2 RESTRAINTS
5.2.2.1 High cost of advanced hematology analyzers
5.2.3 OPPORTUNITIES
5.2.3.1 Increasing uptake of automated hematology analyzers
5.2.3.2 Growth potential of emerging economies
5.2.3.3 Emergence of microfluidics
5.2.4 CHALLENGES
5.2.4.1 Stringent regulatory guidelines
5.2.4.2 Shortage of skilled professionals in emerging markets
5.3 REGULATORY SCENARIO
5.3.1 REGULATORY BODIES, GOVERNMENT AGENCIES AND OTHER ORGANIZATIONS
5.3.2 REGULATORY TRENDS
5.3.2.1 North America
5.3.2.1.1 US
5.3.2.2 Europe
5.3.2.3 Asia Pacific
5.3.2.3.1 India
5.3.2.3.2 China
5.4 REIMBURSEMENT SCENARIO
5.5 VALUE CHAIN ANALYSIS
5.5.1 RESEARCH & DEVELOPMENT
5.5.2 PROCUREMENT & PRODUCT DEVELOPMENT
5.5.3 MARKETING, SALES, AND DISTRIBUTION
5.6 SUPPLY CHAIN ANALYSIS
5.6.1 PROMINENT COMPANIES
5.6.2 SMALL & MEDIUM-SIZED ENTERPRISES
5.6.3 END USERS
5.7 ECOSYSTEM ANALYSIS
5.8 PORTER’S FIVE FORCES ANALYSIS
5.8.1 DEGREE OF COMPETITION
5.8.2 BARGAINING POWER OF BUYERS
5.8.3 BARGAINING POWER OF SUPPLIERS
5.8.4 THREAT OF NEW ENTRANTS
5.8.5 THREAT OF SUBSTITUTES
5.9 TRADE DATA ANALYSIS
5.10 PATENT ANALYSIS
5.11 PRICING ANALYSIS
5.12 TECHNOLOGY ANALYSIS
5.12.1 KEY TECHNOLOGIES
5.12.1.1 Flow cytometry
5.12.1.2 Digital microscopy and image analysis
5.12.1.3 Polymerase chain reaction (PCR) and next-generation sequencing (NGS)
5.12.1.4 Microfluidics
5.12.2 ADJACENT TECHNOLOGIES
5.12.2.1 Bioinformatics
5.12.2.2 Wearable health technology
5.12.2.3 Point-of-care testing (POCT) devices
5.12.3 COMPLEMENTARY TECHNOLOGIES
5.12.3.1 Immunohistochemistry (IHC)
5.12.3.2 Spectrophotometry
5.12.3.3 Serological testing
5.13 KEY CONFERENCES AND EVENTS, 2024
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
5.14.2 KEY BUYING CRITERIA
5.15 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.16 INVESTMENT & FUNDING SCENARIO
5.17 UNMET NEEDS
5.18 USE OF GENERATIVE AI IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE
6.1 INTRODUCTION
6.2 HEMATOLOGY PRODUCTS & SERVICES
6.2.1 REAGENTS & CONSUMABLES
6.2.1.1 Hematology reagents
6.2.1.1.1 Growing preference for reagent rental business models to drive market
6.2.1.2 Hematology consumables
6.2.1.2.1 Recurring requirement to boost demand
6.2.1.3 Controls & calibrators
6.2.1.3.1 Ability to monitor multiple parameters to fuel uptake
6.2.1.4 Slide stainers & makers
6.2.1.4.1 Ability to provide reliable & uniform staining results to fuel uptake
6.2.2 INSTRUMENTS
6.2.2.1 5-part and 6-part fully automated hematology analyzers
6.2.2.1.1 Identification and classification of WBCs to drive market
6.2.2.2 3-part fully automated hematology analyzers
6.2.2.2.1 Low maintenance costs to fuel uptake
6.2.2.3 Point-of-care testing hematology analyzers
6.2.2.3.1 Increasing preference towards home testing of blood levels to support market growth
6.2.2.4 Semi-automated hematology analyzers
6.2.2.4.1 Need for manual interruption to restrain market adoption
6.2.3 SERVICES
6.2.3.1 High adoption of diagnostic techniques to boost demand
6.3 HEMOSTASIS PRODUCTS & SERVICES
6.3.1 HEMOSTASIS REAGENTS & CONSUMABLES
6.3.1.1 Rising prevalence of coagulation disorders to support growth
6.3.2 HEMOSTASIS INSTRUMENTS
6.3.2.1 High productivity with low complexities to drive market
6.3.3 HEMOSTASIS SERVICES
6.3.3.1 Advancements in hemostasis diagnostic techniques to support market growth
6.4 IMMUNOHEMATOLOGY PRODUCTS & SERVICES
6.4.1 IMMUNOHEMATOLOGY REAGENTS & CONSUMABLES
6.4.1.1 Development of novel immunohematology reagents to drive market
6.4.2 IMMUNOHEMATOLOGY INSTRUMENTS
6.4.2.1 Growing automation in immunohematology labs to boost demand
6.4.3 SERVICES
6.4.3.1 Provision of customer-focused care to support market growth
7 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE
7.1 INTRODUCTION
7.2 LOW-RANGE HEMATOLOGY ANALYZERS
7.2.1 LOW OPERATING EXPENSES TO BOOST DEMAND
7.3 HIGH-RANGE HEMATOLOGY ANALYZERS
7.3.1 HIGH ACCURACY AND MULTI-PARAMETER APPROACH TO DRIVE MARKET
7.4 MID-RANGE HEMATOLOGY ANALYZERS
7.4.1 INTEGRATION WITH QUALITY CONTROL SOFTWARE TO SUPPORT MARKET GROWTH
8 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION
8.1 INTRODUCTION
8.2 HEMORRHAGIC CONDITIONS
8.2.1 ABILITY TO TRACK HEMOGLOBIN AND HEMATOCRIT VALUES TO DRIVE MARKET
8.3 INFECTIOUS DISEASES
8.3.1 AVAILABILITY OF HIGH-RESOLUTION HEMATOLOGY SCREENING TO PROPEL MARKET
8.4 IMMUNE SYSTEM DISORDERS
8.4.1 GROWING USE OF POC DIAGNOSTICS AND IMMUNOASSAYS TO PROPEL MARKET
8.5 BLOOD CANCER
8.5.1 DETERMINATION OF HEMATOLOGICAL MALIGNANCIES TO FUEL UPTAKE
8.6 ANEMIA
8.6.1 ABILITY TO IDENTIFY ISOCHROMATIC AND MICROCYTIC ANEMIA TO SUPPORT MARKET GROWTH
8.7 OTHER APPLICATIONS
9 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE
9.1 INTRODUCTION
9.2 STANDALONE ANALYZERS
9.2.1 HIGH UPTAKE IN HOSPITALS AND REFERENCE LABORATORIES FOR CRITICAL CARE SETTINGS TO PROPEL MARKET
9.3 POINT-OF-CARE ANALYZERS
9.3.1 LOW SAMPLE REQUIREMENTS AND REMOTE CARE AVAILABILITY TO BOOST DEMAND
10 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER
10.1 INTRODUCTION
10.2 COMMERCIAL SERVICE PROVIDERS
10.2.1 GROWING OUTSOURCING OF R&D ACTIVITIES AND ABILITY TO PERFORM HIGH VOLUME OF TESTS TO PROPEL MARKET
10.3 HOSPITAL LABORATORIES
10.3.1 PROVISION OF POC & FULLY AUTOMATED ANALYZERS TO DRIVE MARKET
10.4 GOVERNMENT REFERENCE LABORATORIES
10.4.1 FREE SERVICES AND RAPID TURNAROUND TIME TO FUEL UPTAKE
10.5 RESEARCH & ACADEMIC INSTITUTES
10.5.1 INCREASING NUMBER OF DRUG DISCOVERY & RESEARCH ACTIVITIES TO SUPPORT MARKET GROWTH
11 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY REGION
11.1 INTRODUCTION
11.2 NORTH AMERICA
11.2.1 US
11.2.1.1 Rising incidence of anemia and hemophilia to drive market
11.2.2 CANADA
11.2.2.1 Growth in organ transplantation procedures to boost demand
11.3 EUROPE
11.3.1 GERMANY
11.3.1.1 Rising prevalence of HIV to drive market
11.3.2 FRANCE
11.3.2.1 Stringent regulatory protocols in diagnostics to propel market
11.3.3 UK
11.3.3.1 Rising number of organ transplant procedures to support market growth
11.3.4 ITALY
11.3.4.1 Growing acceptance of hematology-based diagnostics to boost demand
11.3.5 SPAIN
11.3.5.1 Rising establishment of reference laboratories to drive market
11.3.6 REST OF EUROPE
11.4 ASIA PACIFIC
11.4.1 CHINA
11.4.1.1 Large target patient population to drive market
11.4.2 JAPAN
11.4.2.1 Rising cases of influenza to support market growth
11.4.3 INDIA
11.4.3.1 Rising cases of dengue and malaria to boost demand
11.4.4 AUSTRALIA
11.4.4.1 Rising prevalence of celiac disease to drive market
11.4.5 SOUTH KOREA
11.4.5.1 High healthcare expenditure and introduction of medical coverage for blood transfusion to support market growth
11.4.6 REST OF ASIA PACIFIC
11.5 LATIN AMERICA
11.5.1 BRAZIL
11.5.1.1 Investments by leading hematology analyzers & reagent manufacturers to drive market
11.5.2 MEXICO
11.5.2.1 Growing requirement for glycosylated hemoglobin analysis tests to fuel uptake
11.5.3 REST OF LATIN AMERICA
11.6 MIDDLE EAST & AFRICA
11.6.1 GCC COUNTRIES
11.6.1.1 Developments in healthcare infrastructure to drive market
11.6.2 REST OF MIDDLE EAST & AFRICA
12 COMPETITIVE LANDSCAPE
12.1 INTRODUCTION
12.2 KEY PLAYERS STRATEGIES/RIGHT TO WIN
12.2.1 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
12.3 REVENUE ANALYSIS
12.4 MARKET SHARE ANALYSIS
12.4.1 HEMATOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
12.4.2 HEMOSTASIS PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
12.4.3 IMMUNOHEMATOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
12.4.4 RANKING OF KEY MARKET PLAYERS
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
12.5.1 STARS
12.5.2 EMERGING LEADERS
12.5.3 PERVASIVE PLAYERS
12.5.4 PARTICIPANTS
12.5.5 COMPETITIVE FOOTPRINT: KEY PLAYERS, 2023
12.5.5.1 Company footprint
12.5.5.2 Product & service footprint
12.5.5.3 Application footprint
12.5.5.4 End-user footprint
12.5.5.5 Region footprint
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023
12.6.1 PROGRESSIVE COMPANIES
12.6.2 RESPONSIVE COMPANIES
12.6.3 DYNAMIC COMPANIES
12.6.4 STARTING BLOCKS
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023
12.7 COMPANY VALUATION & FINANCIAL METRICS
12.7.1 FINANCIAL METRICS
12.7.2 COMPANY VALUATION
12.8 BRAND/PRODUCT COMPARISON
12.9 COMPETITIVE SCENARIO
12.9.1 PRODUCT/SERVICE LAUNCHES & APPROVALS
12.9.2 DEALS
12.9.3 EXPANSIONS
13 COMPANY PROFILES
13.1 KEY PLAYERS
13.1.1 SYSMEX CORPORATION
13.1.1.1 Business overview
13.1.1.2 Products/Services offered
13.1.1.3 Recent developments
13.1.1.3.1 Product/Service launches
13.1.1.3.2 Expansions
13.1.1.4 MnM view
13.1.1.4.1 Key strengths
13.1.1.4.2 Strategic choices
13.1.1.4.3 Weaknesses and competitive threats
13.1.2 DANAHER CORPORATION
13.1.2.1 Business overview
13.1.2.2 Products/Services offered
13.1.2.3 MnM view
13.1.2.3.1 Key strengths
13.1.2.3.2 Strategic choices
13.1.2.3.3 Weaknesses and competitive threats
13.1.3 SIEMENS HEALTHINEERS
13.1.3.1 Business overview
13.1.3.2 Products/Services offered
13.1.3.3 Recent developments
13.1.3.3.1 Product/Service launches
13.1.3.3.2 Deals
13.1.3.4 MnM view
13.1.3.4.1 Key strengths
13.1.3.4.2 Strategic choices
13.1.3.4.3 Weaknesses and competitive threats
13.1.4 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.
13.1.4.1 Business overview
13.1.4.2 Products/Services offered
13.1.4.3 MnM view
13.1.4.3.1 Key strengths
13.1.4.3.2 Strategic choices
13.1.4.3.3 Weaknesses and competitive threats
13.1.5 ABBOTT LABORATORIES
13.1.5.1 Business overview
13.1.5.2 Products/Services offered
13.1.5.3 Recent developments
13.1.5.3.1 Product approvals
13.1.5.4 MnM view
13.1.5.4.1 Key strengths
13.1.5.4.2 Strategic choices
13.1.5.4.3 Weaknesses and competitive threats
13.1.6 DIATRON
13.1.6.1 Business overview
13.1.6.2 Products/Services offered
13.1.6.3 Recent developments
13.1.6.3.1 Expansions
13.1.7 DREW SCIENTIFIC
13.1.7.1 Business overview
13.1.7.2 Products/Services offered
13.1.8 BIO-RAD LABORATORIES, INC.
13.1.8.1 Business overview
13.1.8.2 Products/Services offered
13.1.8.3 Recent developments
13.1.8.3.1 Product/Service launches & enhancements
13.1.8.3.2 Deals
13.1.9 HORIBA, LTD.
13.1.9.1 Business overview
13.1.9.2 Products/Services offered
13.1.9.3 Recent developments
13.1.9.3.1 Product/Service launches & approvals
13.1.10 NIHON KOHDEN CORPORATION
13.1.10.1 Business overview
13.1.10.2 Products/Services offered
13.1.10.3 Recent developments
13.1.10.3.1 Product/Service launches
13.1.10.3.2 Expansions
13.1.11 EKF DIAGNOSTICS HOLDINGS PLC
13.1.11.1 Business overview
13.1.11.2 Products/Services offered
13.1.11.3 Recent developments
13.1.11.3.1 Product/Service enhancements
13.1.11.3.2 Deals
13.1.12 BOULE DIAGNOSTICS AB
13.1.12.1 Business overview
13.1.12.2 Products/Services offered
13.1.12.3 Recent developments
13.1.12.3.1 PRODUCT/SERVICE LAUNCHES
13.1.12.3.2 Deals
13.1.13 F. HOFFMANN-LA ROCHE LTD.
13.1.13.1 Business overview
13.1.13.2 Products/Services offered
13.1.13.3 Recent developments
13.1.13.3.1 Deals
13.2 OTHER PLAYERS
13.2.1 BIOSYSTEMS: COMPANY OVERVIEW
13.2.2 QUIDELORTHO CORPORATION: COMPANY OVERVIEW
13.2.3 DRUCKER DIAGNOSTICS: COMPANY OVERVIEW
13.2.4 ELITECH GROUP SAS: COMPANY OVERVIEW
13.2.5 ACCUREX: COMPANY OVERVIEW
13.2.6 STRECK: COMPANY OVERVIEW
13.2.7 NEOMEDICA: COMPANY OVERVIEW
13.2.8 CPC DIAGNOSTICS PVT. LTD.: COMPANY OVERVIEW
13.2.9 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW
13.2.10 SHENZHEN DYMIND BIOTECHNOLOGY CO., LTD.: COMPANY OVERVIEW
13.2.11 PZ CORMAY S.A.: COMPANY OVERVIEW
13.2.12 PIXCELL MEDICAL: COMPANY OVERVIEW
13.2.13 RAYTO LIFE AND ANALYTICAL SCIENCES CO. LTD.: COMPANY OVERVIEW
13.2.14 ANALYTICON BIOTECHNOLOGIES GMBH: COMPANY OVERVIEW
13.2.15 TULIP DIAGNOSTICS (P) LTD.: COMPANY OVERVIEW
14 APPENDIX
14.1 DISCUSSION GUIDE
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
14.3 CUSTOMIZATION OPTIONS
14.4 RELATED REPORTS
14.5 AUTHOR DETAILS
TABLE 1 NORTH AMERICA: LIST OF REGULATORY AUTHORITIES IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
TABLE 2 EUROPE: LIST OF REGULATORY AUTHORITIES IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
TABLE 3 ASIA PACIFIC: LIST OF REGULATORY AUTHORITIES IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
TABLE 4 LATIN AMERICA: LIST OF REGULATORY AUTHORITIES IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
TABLE 5 MIDDLE EAST & AFRICA: LIST OF REGULATORY AUTHORITIES IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
TABLE 6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
TABLE 7 IMPORT DATA FOR HEMATOLOGY ANALYZERS (HS CODE 902780), BY COUNTRY, 2019?2023 (USD)
TABLE 8 EXPORT DATA FOR HEMATOLOGY ANALYZERS (HS CODE 902780), BY COUNTRY, 2019?2023 (USD)
TABLE 9 AVERAGE SELLING PRICE TREND OF HEMATOLOGY PRODUCTS, BY REGION,
2021–2023
TABLE 10 HEMATOLOGY ANALYZERS AND REAGENTS: LIST OF MAJOR CONFERENCES & EVENTS
TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEMATOLOGY PRODUCTS (%)
TABLE 12 KEY BUYING CRITERIA FOR HEMATOLOGY ANALYZERS AND REAGENTS PRODUCTS
TABLE 13 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: CURRENT UNMET NEEDS
TABLE 14 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 15 HEMATOLOGY PRODUCTS & SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 16 HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 17 HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 18 HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 19 HEMATOLOGY REAGENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 20 HEMATOLOGY CONSUMABLES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 21 HEMATOLOGY CONTROLS & CALIBRATORS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 22 HEMATOLOGY SLIDE STAINERS & MAKERS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 23 HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 24 HEMATOLOGY INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 25 5-PART AND 6-PART FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET,
BY REGION, 2022–2029 (USD MILLION)
TABLE 26 3-PART FULLY AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 27 POINT-OF-CARE TESTING HEMATOLOGY ANALYZERS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 28 SEMI-AUTOMATED HEMATOLOGY ANALYZERS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 29 HEMATOLOGY SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 30 HEMOSTASIS PRODUCTS & SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 31 HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 32 HEMOSTASIS REAGENTS & CONSUMABLES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 33 HEMOSTASIS INSTRUMENTS MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 34 HEMOSTASIS SERVICES MARKET, BY REGION, 2022–2029 (USD MILLION)
TABLE 35 IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 36 IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 37 IMMUNOHEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 38 IMMUNOHEMATOLOGY INSTRUMENTS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 39 IMMUNOHEMATOLOGY SERVICES MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 40 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE,
2022–2029 (USD MILLION)
TABLE 41 LOW-RANGE HEMATOLOGY ANALYZERS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 42 HIGH-RANGE HEMATOLOGY ANALYZERS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 43 MID-RANGE HEMATOLOGY ANALYZERS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 44 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION,
2022–2029 (USD MILLION)
TABLE 45 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR HEMORRHAGIC CONDITIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 46 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR INFECTIOUS DISEASES, BY REGION, 2022–2029 (USD MILLION)
TABLE 47 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR IMMUNE SYSTEM DISORDERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 48 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR BLOOD CANCER,
BY REGION, 2022–2029 (USD MILLION)
TABLE 49 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR ANEMIA, BY REGION, 2022–2029 (USD MILLION)
TABLE 50 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR OTHER APPLICATIONS, BY REGION, 2022–2029 (USD MILLION)
TABLE 51 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE,
2022–2029 (USD MILLION)
TABLE 52 STANDALONE HEMATOLOGY ANALYZERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 53 POINT-OF-CARE HEMATOLOGY ANALYZERS, BY REGION,
2022–2029 (USD MILLION)
TABLE 54 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER,
2022–2029 (USD MILLION)
TABLE 55 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR COMMERCIAL SERVICE PROVIDERS, BY REGION, 2022–2029 (USD MILLION)
TABLE 56 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR HOSPITAL LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 57 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR GOVERNMENT REFERENCE LABORATORIES, BY REGION, 2022–2029 (USD MILLION)
TABLE 58 HEMATOLOGY ANALYZERS AND REAGENTS MARKET FOR RESEARCH & ACADEMIC INSTITUTES, BY REGION, 2022–2029 (USD MILLION)
TABLE 59 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY REGION,
2022–2029 (USD MILLION)
TABLE 60 HEMATOLOGY ANALYZERS VOLUME, BY TYPE, 2023 (UNITS)
TABLE 61 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 62 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 63 NORTH AMERICA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 64 NORTH AMERICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 65 NORTH AMERICA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 66 NORTH AMERICA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 67 NORTH AMERICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 68 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRICE RANGE, 2022–2029 (USD MILLION)
TABLE 69 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 70 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY USAGE TYPE, 2022–2029 (USD MILLION)
TABLE 71 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 72 US: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 73 US: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 74 US: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 75 US: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 76 US: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 77 US: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 78 CANADA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 79 CANADA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 80 CANADA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 81 CANADA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 82 CANADA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 83 CANADA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 84 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 85 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 86 EUROPE: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 87 EUROPE: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 88 EUROPE: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 89 EUROPE: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 90 EUROPE: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 91 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2022–2029 (USD MILLION)
TABLE 92 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 93 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE, 2022–2029 (USD MILLION)
TABLE 94 EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER, 2022–2029 (USD MILLION)
TABLE 95 GERMANY: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 96 GERMANY: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 97 GERMANY: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 98 GERMANY: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 99 GERMANY: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 100 GERMANY: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 101 FRANCE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 102 FRANCE: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 103 FRANCE: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 104 FRANCE: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 105 FRANCE: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 106 FRANCE: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 107 UK: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 108 UK: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 109 UK: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 110 UK: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 111 UK: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 112 UK: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 113 ITALY: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 114 ITALY: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 115 ITALY: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 116 ITALY: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 117 ITALY: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 118 ITALY: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 119 SPAIN: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 120 SPAIN: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 121 SPAIN: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 122 SPAIN: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 123 SPAIN: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 124 SPAIN: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 125 REST OF EUROPE: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 126 REST OF EUROPE: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 127 REST OF EUROPE: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 128 REST OF EUROPE: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 129 REST OF EUROPE: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 130 REST OF EUROPE: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 131 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 132 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 133 ASIA PACIFIC: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 134 ASIA PACIFIC: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 135 ASIA PACIFIC: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 136 ASIA PACIFIC: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 137 ASIA PACIFIC: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 138 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2022–2029 (USD MILLION)
TABLE 139 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 140 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY USAGE TYPE, 2022–2029 (USD MILLION)
TABLE 141 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 142 CHINA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 143 CHINA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 144 CHINA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 145 CHINA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 146 CHINA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 147 CHINA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 148 JAPAN: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 149 JAPAN: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 150 JAPAN: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 151 JAPAN: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 152 JAPAN: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 153 JAPAN: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 154 INDIA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 155 INDIA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 156 INDIA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 157 INDIA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 158 INDIA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 159 INDIA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 160 AUSTRALIA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 161 AUSTRALIA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 162 AUSTRALIA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 163 AUSTRALIA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 164 AUSTRALIA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 165 AUSTRALIA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 166 SOUTH KOREA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 167 SOUTH KOREA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 168 SOUTH KOREA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 169 SOUTH KOREA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 170 SOUTH KOREA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 171 SOUTH KOREA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 172 REST OF ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 173 REST OF ASIA PACIFIC: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 174 REST OF ASIA PACIFIC: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 175 REST OF ASIA PACIFIC: HEMATOLOGY REAGENTS & CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 176 REST OF ASIA PACIFIC: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 177 REST OF ASIA PACIFIC: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 178 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY COUNTRY, 2022–2029 (USD MILLION)
TABLE 179 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 180 LATIN AMERICA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 181 LATIN AMERICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 182 LATIN AMERICA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 183 LATIN AMERICA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 184 LATIN AMERICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 185 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE, 2022–2029 (USD MILLION)
TABLE 186 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 187 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY USAGE TYPE, 2022–2029 (USD MILLION)
TABLE 188 LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 189 BRAZIL: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 190 BRAZIL: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 191 BRAZIL: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 192 BRAZIL: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 193 BRAZIL: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 194 BRAZIL: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 195 MEXICO: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 196 MEXICO: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 197 MEXICO: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 198 MEXICO: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 199 MEXICO: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 200 MEXICO: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 201 REST OF LATIN AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 202 REST OF LATIN AMERICA: HEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 203 REST OF LATIN AMERICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 204 REST OF LATIN AMERICA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 205 REST OF LATIN AMERICA: HEMOSTASIS PRODUCTS & SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 206 REST OF LATIN AMERICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 207 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY REGION, 2022–2029 (USD MILLION)
TABLE 208 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 209 MIDDLE EAST & AFRICA: HEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 210 MIDDLE EAST & AFRICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 211 MIDDLE EAST & AFRICA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 212 MIDDLE EAST & AFRICA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 213 MIDDLE EAST & AFRICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 214 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRICE RANGE, 2022–2029 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY APPLICATION, 2022–2029 (USD MILLION)
TABLE 216 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY USAGE TYPE, 2022–2029 (USD MILLION)
TABLE 217 MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY END USER, 2022–2029 (USD MILLION)
TABLE 218 GCC COUNTRIES: HEMATOLOGY ANALYZERS AND REAGENTS MARKET,
BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 219 GCC COUNTRIES: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 220 GCC COUNTRIES: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 221 GCC COUNTRIES: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 222 GCC COUNTRIES: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE,
2022–2029 (USD MILLION)
TABLE 223 GCC COUNTRIES: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET,
BY TYPE, 2022–2029 (USD MILLION)
TABLE 224 REST OF MIDDLE EAST & AFRICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2022–2029 (USD MILLION)
TABLE 225 REST OF MIDDLE EAST & AFRICA: HEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 226 REST OF MIDDLE EAST & AFRICA: HEMATOLOGY INSTRUMENTS MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 227 REST OF MIDDLE EAST & AFRICA: HEMATOLOGY REAGENTS & CONSUMABLES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 228 REST OF MIDDLE EAST & AFRICA: HEMOSTASIS PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 229 REST OF MIDDLE EAST & AFRICA: IMMUNOHEMATOLOGY PRODUCTS & SERVICES MARKET, BY TYPE, 2022–2029 (USD MILLION)
TABLE 230 OVERVIEW OF STRATEGIES DEPLOYED BY KEY MANUFACTURING COMPANIES
TABLE 231 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DEGREE OF COMPETITION
TABLE 232 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PRODUCT & SERVICE FOOTPRINT
TABLE 233 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: APPLICATION FOOTPRINT
TABLE 234 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: END-USER FOOTPRINT
TABLE 235 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: REGION FOOTPRINT
TABLE 236 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DETAILED LIST OF
KEY STARTUP/SME PLAYERS
TABLE 237 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: COMPETITIVE BENCHMARKING OF KEY EMERGING PLAYERS/STARTUPS
TABLE 238 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020–JUNE 2024
TABLE 239 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DEALS,
JANUARY 2020–JUNE 2024
TABLE 240 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: EXPANSIONS, JANUARY 2020–JUNE 2024
TABLE 241 SYSMEX CORPORATION: COMPANY OVERVIEW
TABLE 242 SYSMEX CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 243 SYSMEX CORPORATION: PRODUCT/SERVICE LAUNCHES,
JANUARY 2020?JUNE 2024
TABLE 244 SYSMEX CORPORATION: EXPANSIONS, JANUARY 2020?JUNE 2024
TABLE 245 DANAHER CORPORATION: COMPANY OVERVIEW
TABLE 246 DANAHER CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 247 SIEMENS HEALTHINEERS: COMPANY OVERVIEW
TABLE 248 SIEMENS HEALTHINEERS: PRODUCTS/SERVICES OFFERED
TABLE 249 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PRODUCT/SERVICE LAUNCHES, JANUARY 2020?JUNE 2024
TABLE 250 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DEALS,
JANUARY 2020?JUNE 2024
TABLE 251 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.: COMPANY OVERVIEW
TABLE 252 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:
PRODUCTS/SERVICES OFFERED
TABLE 253 ABBOTT LABORATORIES: COMPANY OVERVIEW
TABLE 254 ABBOTT LABORATORIES: PRODUCTS/SERVICES OFFERED
TABLE 255 ABBOTT LABORATORIES: PRODUCT APPROVALS, JANUARY 2020?JUNE 2024
TABLE 256 DIATRON: COMPANY OVERVIEW
TABLE 257 DIATRON: PRODUCTS/SERVICES OFFERED
TABLE 258 DIATRON: EXPANSIONS, JANUARY 2020?JUNE 2024
TABLE 259 DREW SCIENTIFIC: COMPANY OVERVIEW
TABLE 260 DREW SCIENTIFIC: PRODUCTS/SERVICES OFFERED
TABLE 261 BIO-RAD LABORATORIES, INC.: COMPANY OVERVIEW
TABLE 262 BIO-RAD LABORATORIES, INC.: PRODUCTS/SERVICES OFFERED
TABLE 263 BIO-RAD LABORATORIES, INC.: PRODUCT/SERVICE LAUNCHES & ENHANCEMENTS, JANUARY 2020?JUNE 2024
TABLE 264 BIO-RAD LABORATORIES, INC.: DEALS, JANUARY 2020?JUNE 2024
TABLE 265 HORIBA, LTD.: COMPANY OVERVIEW
TABLE 266 HORIBA, LTD.: PRODUCTS/SERVICES OFFERED
TABLE 267 HORIBA, LTD.: PRODUCT/SERVICE LAUNCHES & APPROVALS, JANUARY 2020?JUNE 2024
TABLE 268 NIHON KOHDEN CORPORATION: COMPANY OVERVIEW
TABLE 269 NIHON KOHDEN CORPORATION: PRODUCTS/SERVICES OFFERED
TABLE 270 NIHON KOHEN CORPORATION: PRODUCT/SERVICE LAUNCHES, JANUARY 2020?JUNE 2024
TABLE 271 NIHON KOHDEN CORPORATION: EXPANSIONS, JANUARY 2020?JUNE 2024
TABLE 272 EKF DIAGNOSTICS HOLDINGS PLC: COMPANY OVERVIEW
TABLE 273 EKF DIAGNOSTICS HOLDINGS PLC: PRODUCTS/SERVICES OFFERED
TABLE 274 EKF DIAGNOSTICS HOLDINGS PLC: PRODUCT/SERVICE ENHANCEMENTS, JANUARY 2020?JUNE 2024
TABLE 275 EKF DIAGNOSTICS HOLDINGS PLC: DEALS, JANUARY 2020?JUNE 2024
TABLE 276 BOULE DIAGNOSTICS AB: COMPANY OVERVIEW
TABLE 277 BOULE DIAGNOSTICS AB: PRODUCTS/SERVICES OFFERED
TABLE 278 BOULE DIAGNOSTICS AB: PRODUCT/SERVICE LAUNCHES,
JANUARY 2020?JUNE 2024
TABLE 279 BOULE DIAGNOSTICS AB: DEALS, JANUARY 2020?JUNE 2024
TABLE 280 F. HOFFMANN-LA ROCHE LTD.: COMPANY OVERVIEW
TABLE 281 F. HOFFMANN-LA ROCHE LTD.: PRODUCTS/SERVICES OFFERED
TABLE 282 F. HOFFMANN LA-ROCHE LTD.: DEALS, JANUARY 2020?JUNE 2024
FIGURE 1 MARKET SEGMENTATION
FIGURE 2 RESEARCH DESIGN
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION
FIGURE 4 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING
FIGURE 5 MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS (2023)
FIGURE 6 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: MARKET SIZE ESTIMATION METHODOLOGY:
FIGURE 7 DATA TRIANGULATION METHODOLOGY
FIGURE 8 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD MILLION)
FIGURE 9 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY APPLICATION,
2024 VS. 2029 (USD MILLION)
FIGURE 10 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY USAGE TYPE,
2024 VS. 2029 (USD MILLION)
FIGURE 11 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY PRICE RANGE,
2024 VS. 2029 (USD MILLION)
FIGURE 12 HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY END USER,
2024 VS. 2029 (USD MILLION)
FIGURE 13 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: REGIONAL SNAPSHOT
FIGURE 14 INCREASING INCIDENCE OF BLOOD DISORDERS AND RISING NUMBER OF
BLOOD DONATIONS TO DRIVE MARKET
FIGURE 15 HEMATOLOGY PRODUCTS & SERVICES SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
FIGURE 16 CHINA TO REGISTER HIGHEST GROWTH RATE DURING FORECAST PERIOD
FIGURE 17 NORTH AMERICA TO DOMINATE HEMATOLOGY ANALYZERS AND REAGENTS MARKET DURING FORECAST PERIOD
FIGURE 18 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
FIGURE 19 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: VALUE CHAIN ANALYSIS
FIGURE 20 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: SUPPLY CHAIN ANALYSIS
FIGURE 21 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: ECOSYSTEM ANALYSIS
FIGURE 22 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: ECOSYSTEM MARKET MAP
FIGURE 23 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PORTER’S FIVE FORCES ANALYSIS
FIGURE 24 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: PATENT ANALYSIS
FIGURE 25 AVERAGE SELLING PRICE TREND OF HEMATOLOGY ANALYZERS, BY PRODUCT, 2023 (USD)
FIGURE 26 AVERAGE SELLING PRICE TREND OF HEMATOLOGY REAGENTS, BY PRODUCT, 2023 (USD)
FIGURE 27 AVERAGE SELLING PRICE TREND OF HEMATOLOGY ANALYZERS, BY REGION,
2023 (USD)
FIGURE 28 AVERAGE SELLING PRICE TREND OF HEMATOLOGY REAGENTS, BY REGION,
2023 (USD)
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR HEMATOLOGY PRODUCTS
FIGURE 30 KEY BUYING CRITERIA FOR HEMATOLOGY ANALYZERS AND PRODUCTS
FIGURE 31 TRENDS/DISRUPTIONS IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET
FIGURE 32 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: NUMBER OF DEALS & FUNDING ACTIVITIES, BY KEY PLAYER, 2018–2022 (USD MILLION)
FIGURE 33 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: NUMBER OF INVESTOR DEALS, BY KEY PLAYER, 2018–2022 (USD MILLION)
FIGURE 34 VALUE OF INVESTOR DEALS IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET, BY KEY PLAYER, 2018–2022 (USD MILLION)
FIGURE 35 NORTH AMERICA: HEMATOLOGY ANALYZERS AND REAGENTS MARKET SNAPSHOT
FIGURE 36 ASIA PACIFIC: HEMATOLOGY ANALYZERS AND REAGENTS MARKET SNAPSHOT
FIGURE 37 REVENUE ANALYSIS OF KEY PLAYERS IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET (2019?2023)
FIGURE 38 MARKET SHARE ANALYSIS OF KEY PLAYERS IN HEMATOLOGY ANALYZERS AND REAGENTS MARKET (2023)
FIGURE 39 HEMATOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 40 HEMOSTASIS PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 41 IMMUNOHEMATOLOGY PRODUCTS MARKET SHARE, BY KEY PLAYER, 2023
FIGURE 42 RANKING OF KEY PLAYERS IN HEMATOLOGY ANALYZERS AND
REAGENTS MARKET, 2023
FIGURE 43 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
FIGURE 44 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: COMPANY FOOTPRINT
FIGURE 45 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
FIGURE 46 EV/EBITDA OF KEY VENDORS
FIGURE 47 YEAR-TO-DATE (YTD) PRICE TOTAL RETURN AND 5-YEAR STOCK BETA OF
KEY VENDORS
FIGURE 48 HEMATOLOGY ANALYZERS AND REAGENTS MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS
FIGURE 49 SYSMEX CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 50 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 51 SIEMENS HEALTHINEERS: COMPANY SNAPSHOT (2023)
FIGURE 52 SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.:
COMPANY SNAPSHOT (2023)
FIGURE 53 ABBOTT LABORATORIES: COMPANY SNAPSHOT (2023)
FIGURE 54 BIO-RAD LABORATORIES, INC.: COMPANY SNAPSHOT (2023)
FIGURE 55 HORIBA, LTD.: COMPANY SNAPSHOT (2023)
FIGURE 56 NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2023)
FIGURE 57 EKF DIAGNOSTICS HOLDINGS PLC: COMPANY SNAPSHOT (2023)
FIGURE 58 BOULE DIAGNOSTICS AB: COMPANY SNAPSHOT (2023)
FIGURE 59 F. HOFFMANN-LA ROCHE LTD.: COMPANY SNAPSHOT (2023)
